It just got easier to navigate digital health product regulations
Learn how to navigate digital product regs and build a strong regulatory strategy with DiMe’s new course.
Kentucky sues major PBMs over rising insulin prices
A string of states and cities have filed recent suits against PBMs and drug manufacturers alleging they work in tandem to raise the cost of insulin.
Health insurers ignore surprise billing decisions, providers allege
Payers didn’t reimburse doctors in more than half of arbitration award cases, according to a survey from clinician group Americans for Fair Health Care.
Former CMS, BCBS exec steps up as CEO of OptumRx in UnitedHealth leadership shakeup
Patrick Conway is replacing Heather Cianfrocco as CEO of UnitedHealth’s pharmacy benefit manager as part of a chain reaction of executive moves.
CHS announces new strategic initiatives to get back in black
After CHS posted a net income loss of $38 million on Wednesday, leadership told investors they have a plan to recover.
How Henry Ford Health uses data to combat inflation and improve its supply chain
The healthcare and hospital group leverages data to track costs, engage with suppliers and fortify itself against future disruptions.
AI reduces radiologist workload in mammography clinical trial but expert urges caution
The trial linked the AI-supported screen-reading procedure, ScreenPoint Medical’s Transpara, to a 44% reduction in radiologist workload.
‘Chaotic’ digital health market needs independent evaluation, new institute says
Independent evaluation could help the healthcare industry figure out which digital health products are backed by evidence, argues Caroline Pearson, executive director of the nonprofit Peterson Center on Healthcare.
U.S reaches record low uninsured rate just prior to Medicaid redeterminations
The uninsured rate fell to a record low in March, but Medicaid eligibility checks could reverse that progress, according to experts.
Cigna checks medical cost growth as Evernorth earnings boosted by GLP-1s
Cigna’s medical costs in the quarter were “well-controlled,” one analyst said, but faced pressure from higher estimated risk-adjustment payments in the ACA individual exchanges.